Ironwood Pharmaceuticals Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 34.32M43.86M65.87M150.25M22.88M76.44M149.56M273.96M298.28M346.64M428.41M389.52M413.75M410.60M442.74M351.41M
Cost of Revenue 0.96M7.20M5.29M0.01M1.87M19.10M32.75M23.88M3.14M
Gross Profit 149.28M15.68M71.14M149.54M272.09M279.18M313.89M404.54M386.39M
Operating items
Amortization - Intangibles 0.98M6.21M8.11M
Research & Development 76.10M77.45M86.09M113.47M102.38M101.89M108.75M139.49M88.14M101.06M115.04M88.06M70.41M44.27M116.08M111.42M
Selling, General & Administrative 19.04M27.17M45.92M92.54M123.23M118.33M125.25M173.28M231.18M219.68M172.45M140.00M111.13M115.99M158.31M144.27M
Restructuring Costs 14.71M3.62M15.40M
Other Operating Expenses 17.00M49.28M25.58M17.65M13.05M-5.69M161.86M17.18M3.12M-0.04M1,113.77M2.59M
Operating Expenses 95.14M104.62M132.01M223.01M274.88M245.81M251.64M325.83M313.64M497.31M308.29M246.58M181.49M160.26M1,388.16M258.29M
Operating Income -60.82M-60.77M-66.14M-72.76M-252.00M-169.37M-102.09M-51.87M-15.36M-150.67M120.12M142.94M232.26M250.34M-945.43M93.12M
EBIT -60.82M-60.77M-66.14M-72.76M-252.00M-169.37M-102.09M-51.87M-15.36M-150.67M120.12M142.94M232.26M250.34M-945.43M93.12M
Non-operating items
Non Operating Investment Income -9.93M8.15M-3.28M-8.74M3.02M-6.13M-1.18M0.18M0.02M
Interest & Investment Income 0.24M0.61M0.46M0.20M0.19M0.26M0.44M1.17M2.11M2.99M2.86M1.50M0.73M9.50M18.97M4.47M
Other Non Operating Income 0.60M0.99M0.90M0.29M1.41M0.66M-2.01M-30.98M0.33M0.43M-0.29M0.70M0.79M
Non Operating Income 0.52M1.41M1.29M0.14M-20.81M-20.25M-40.58M-29.84M-39.55M-43.48M-61.18M-34.08M-31.60M2.08M93.39M-27.93M
Net income details
EBT -60.29M-59.35M-64.85M-72.62M-272.81M-194.15M58.94M108.86M200.66M252.42M-1174.60M167.09M
Tax Provisions -0.30M-2.94M0.00M2.70M-327.80M77.40M83.50M64.32M
Profit After Tax -73.31M-56.41M-64.85M-72.62M-272.81M-142.67M-81.71M-116.94M-282.37M58.94M106.18M528.45M175.06M-1031.56M0.88M
Income from Non-Controlling Interests -2.13M1.12M-29.32M
Income from Continuing Operations -60.00M-56.41M-64.85M-72.62M-272.81M-194.15M58.94M106.16M528.46M175.02M-1258.10M102.77M
Consolidated Net Income -13.31M4.55M-64.85M-72.62M-272.81M-62.02M-88.22M-37.44M106.16M528.46M175.02M-1258.10M102.77M
Income towards Parent Company -13.31M4.55M-64.85M-72.62M-272.81M-62.02M-88.22M-37.44M106.16M528.46M175.02M-1258.10M102.77M
Net Income towards Common Stockholders -71.19M-52.98M-64.85M-72.62M-272.81M-189.62M-142.67M-81.71M-62.02M-88.22M-37.44M106.16M528.46M175.02M-1258.10M102.77M
Additional items
EPS (Basic) -10.00-0.63-0.65-0.68-2.35-1.39-1.00-0.56-0.78-1.850.380.673.261.13-6.450.01
EPS (Weighted Average and Diluted) -10.00-0.59-0.65-0.68-1.850.380.663.210.96-6.450.01
Shares Outstanding (Weighted Average) 94.91M98.83M106.96M107.99M120.90M139.63M142.78M146.22M149.76M154.06M156.82M160.96M163.65M153.40M156.13M160.03M
Shares Outstanding (Diluted Average) 7.12M89.65M99.87M152.63M156.02M160.66M
EBITDA 21.50M106.18M528.45M175.06M
Interest Expenses 0.32M0.20M0.06M0.06M21.00M21.17M31.10M39.15M36.37M37.72M36.60M29.48M31.15M7.60M21.63M33.03M
Tax Rate 0.49%4.96%2.48%30.66%38.49%